论文信息 - CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN). - 字舞流文

CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).

C. Shapiro | C. Fadul | E. Paskett | H. Pang | C. Cirrincione | S. Fleishman | P. Gilman | C. Knox